Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed).


NDAQ:VMD - Post by User

Comment by LongTerm3on Feb 18, 2022 1:47pm
278 Views
Post# 34442680

RE:APR was acquired for 7x adj. EBITDA, VMD at 4.5x adj. EBITDA

RE:APR was acquired for 7x adj. EBITDA, VMD at 4.5x adj. EBITDAAPR expected Adjusted EPS growth is 8 percent next year.

Viemed expected Adjusted EPS growth is over 20 percent next year.

APR also has debt of over 400 Million.

Viemed debt is about 4 Million.    APR has 100 times the debt. That is huge. That is why they were about to get the company at only 7 times ADJ. EBITA. Viemed would go for more. 

APR has about 35 million shares outstanding. If you consider the debt they paid almost $50 a share for APR.
<< Previous
Bullboard Posts
Next >>